Trump announces import tariff up to 200% on generic drugs after 2026 window; India's $9.7bn exports at risk

Read post on businesstoday.in

US President Trump has announced a phased tariff hike on generic drug imports starting August 2026, aiming to reshore pharmaceutical manufacturing to America